基本信息
浏览量:120
职业迁徙
个人简介
Dr. Yaron Ilan is the Director of the Department of Medicine at Hebrew
University Hadassah Medical Center. He is a graduate of the Hebrew
University-Hadassah School of Medicine and completed his internship and
residency at the Hadassah University Medical Center. His post-graduate
training was acquired at the Liver Research Center of Yeshiva University’s
Albert Einstein College of Medicine and Mount Sinai Medical Center and The
Harvard Institute of Medicine of Harvard University. Between 2002 to 2009 he
served as the Vice Dean of the Hebrew University-Hadassah Medical School.
A prolific researcher, he holds over 50 patents for discoveries based on his
research and has authored and co-authored more than 240 articles. Dr Ilan's
main areas of research are Liver immunology; Development of immunemodulatory
drugs for fatty liver disease, type 2 diabetes and inflammatory
bowel disease. He is the inventor of a number of drugs and devices being
developed by several pharmaceutical companies. Dr. Ilan is the founder of
several start up companies and medical director and advisor for several
biotech companies.
研究兴趣
论文共 637 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Yuval Ishay, Joel Neutel,Yotam Kolben,Ram Gelman, Orly Sneh Arbib, Oliver Lopez, Helena Katchman,Rizwana Mohseni,Miriam Kidron,Yaron Ilan
Gastro Hep Advancesno. 3 (2024): 417-425
引用0浏览0引用
0
0
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCESno. 5 (2024)
International Journal of Molecular Sciencesno. 5 (2024): 2683
International journal of applied biology and pharmaceutical technologyno. 02 (2023)
引用0浏览0引用
0
0
Yuval Ishay, Joel Neutel,Yotam Kolben,Ram Gelman, Orly Sneh Arbib, Oliver Lopez, Helena Katchman,Rizwana Mohseni,Miriam Kidron,Yaron Ilan
Gastro Hep Advances (2023)
CLINICAL AND EXPERIMENTAL HEPATOLOGYno. 2 (2023): 164-171
引用0浏览0WOS引用
0
0
CLINICS AND PRACTICEno. 4 (2023): 994-1014
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn